Skye Bioscience, Inc. — Net Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/41589d07-3608-45e8-a9a9-3fd8030cdcf7/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-55.9M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-016394 |
| FY 2024 | $-26.6M | 2024-01-01 – 2024-12-31 | evidence 0001516551-25-000027 |
| FY 2023 | $-37.6M | 2023-01-01 – 2023-12-31 | evidence 0001516551-24-000048 |
| FY 2022 | $-19.5M | 2022-01-01 – 2022-12-31 | evidence 0001516551-23-000038 |
| FY 2021 | $-8.5M | 2021-01-01 – 2021-12-31 | evidence 0001516551-22-000004 |
| FY 2020 | $-6.6M | 2020-01-01 – 2020-12-31 | evidence 0001640334-21-000483 |
| FY 2019 | $1.1M | 2019-01-01 – 2019-12-31 | evidence 0001640334-20-000582 |
| FY 2018 | $-19.2M | 2018-01-01 – 2018-12-31 | evidence 0001640334-19-000379 |
| FY 2017 | $-3.1M | 2017-01-01 – 2017-12-31 | evidence 0001640334-18-000482 |
| FY 2016 | $-3.2M | 2016-01-01 – 2016-12-31 | evidence 0001640334-17-000456 |
| FY 2015 | $-4.8M | 2015-01-01 – 2015-12-31 | evidence 0001640334-16-000847 |
| FY 2014 | $-2.7M | 2014-01-01 – 2014-12-31 | evidence 0001557240-15-000195 |
| FY 2013 | $-120.4k | 2013-01-01 – 2013-12-31 | evidence 0001557240-15-000195 |
| FY 2012 | $2.7k | 2011-03-17 – 2013-04-30 | evidence 0001557240-13-000182 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).